David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.
Andrew D. White is an Associate Professor of Chemical Engineering at the Hajim School of Engineering & Applied Sciences, University of Rochester. He holds a PhD from the University of Washington (2013). His research focuses on automating scientific discovery through AI, particularly leveraging large language models (LLMs) and deep learning techniques in chemistry. His lab develops agents that integrate literature analysis, hypothesis generation, and experimental design to advance fields like molecular dynamics and drug discovery. Education: PhD in Chemical Engineering, University of Washington, 2013 BS/MS (not explicitly stated in text, inferred from career timeline) Research Interests: Large language models for scientific automation Deep learning applications in chemistry and materials science Molecular dynamics simulations Scientific agents and autonomous systems Publications: His work includes groundbreaking studies on closed-loop AI systems for chemistry, federated learning in molecular property prediction, and multi-agent systems for drug discovery. Recent highlights include the Robin system and ChemCrow tools. Awards: Recipient of the NSF Career Award (2018), NIH Outstanding Investigator Award (2020), and the Curtis Teaching Award (2019). He also advises biotech companies and serves on the National Academy of Sciences' Chemical Sciences Roundtable. Grants & Funding: Supported by DOE, NSF (multiple grants including CBET-1751471), NIH (R35GM137966), and LLNL projects. Collaborates with institutions like Argonne National Lab and Qubit Pharmaceuticals. Labs & Teams: Leads the White Lab at Rochester and co-founded FutureHouse, a nonprofit advancing AI-driven scientific discovery. Supervises a multidisciplinary team of PhD students and postdocs in computational chemistry, AI, and biophysics.
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Dr. Xi Chen is a Professor in the Department of Chemistry at the University of California, Davis, where he has been a faculty member since 2003. His research spans carbohydrate chemistry, glycobiology, and cancer biology, with notable contributions to chemoenzymatic methods for glycoconjugate synthesis. Dr. Chen's work focuses on developing hybrid chemical-enzymatic approaches to synthesize complex carbohydrates and glycoconjugates, characterizing glycosyltransferase mechanisms, and designing enzyme mutants for improved catalysis. He also investigates carbohydrate-based diagnostics and therapeutics, particularly in cancer and inflammatory diseases. His recent publications highlight interdisciplinary studies linking carbohydrate metabolism to p53 tumor suppression pathways and RNA-binding protein regulation in cancer. Awards include AAAS Fellow (2015), ACS Isbell Award (2012), and NSF CAREER Award (2006). He earned his Ph.D. at Wayne State University (2000) and B.S. at Xiamen University (1994). Scientific Awards American Association for the Advancement of Science Fellow (2015) Dean's Team Award for Excellence (2013) Carbohydrate Research Award for Creativity (2013) ACS CARB Horace S. Isbell Award (2012)
Babak Hassibi is a Professor of Electrical Engineering and Computing and Mathematical Sciences at the California Institute of Technology (Caltech). He obtained his B.S. from the University of Tehran (1989), M.S. and Ph.D. from Stanford University (1993, 1996), and has held positions at Caltech since 2001, including roles as Assistant Professor, Associate Professor, Professor, and Executive Officer. Education : University of Tehran, B.S. (1989) Stanford University, M.S. and Ph.D. (1993, 1996) Academic Roles : Assistant Professor, Caltech (2001–03) Associate Professor (2003–08) Professor (2008–13) Binder/Amgen Professor (2013–16) Bohn Professor (2016–) Executive Officer for Electrical Engineering (2008–15) Associate Director for Information Science and Technology (2010–12) Research Interests : Babak Hassibi’s work spans Communications , Signal Processing , Control Theory , and Machine Learning . He has contributed to wireless networks, genomic signal processing, multi-antenna systems, robust control, and high-dimensional statistics. His mathematical interests include Random Matrices and Group Representation Theory . Recent Publications highlight his focus on Adaptive Control , Stochastic Optimization , and Quantum Detection . Notable trends include Regret-Optimal Control , Stochastic Mirror Descent , and DNA Microarray Applications . Scientific Awards : Highly Cited Researcher Advising and Grants : He has advised numerous graduate students and postdocs, many of whom now hold prominent positions at institutions like MIT, USC, and Stanford. His research includes collaborations on patents and projects related to Wireless Communications and Genomic Technologies . Labs and Teams : Leads the Hassibi Group at Caltech, which explores nonlinear photonic systems, ultrafast optics, and quantum information processing.
David Juncker is a Professor and Department Chair of the Department of Biomedical Engineering at McGill University. He serves as a Principal Investigator at the McGill University & Genome Quebec Innovation Centre and holds associate memberships in the Department of Neurology and Neurosurgery, Department of Electrical and Computer Engineering, Division of Experimental Medicine, Department of Surgery, and Goodman Cancer Research Centre. His research focuses on micro- and nano-bioengineering technologies for bioanalysis, precision medicine, and organs-on-chips. Key areas include microfluidics, lab-on-a-chip devices, biomedical sensors, medical diagnostics, biomaterials, tissue engineering, and cancer biomarker discovery. His lab develops scalable antibody microarrays, self-powered diagnostic platforms, microfluidic probes for brain tissue perfusion, and nanogradients for neuronal navigation, with applications in cancer diagnostics, global health, and neuroscience. Recent publications (2023-2025) reveal strong emphasis on extracellular vesicle analysis, single-cell proteomics, 3D-printed microfluidic/organ-on-a-chip systems, and capillary-driven circuits. Key trends include low-cost point-of-care diagnostics, advanced circulating tumor cell isolation methods, and biomimetic synthetic vesicles for drug delivery, demonstrating translational potential in early disease detection. Dr. Juncker leads a highly interdisciplinary team comprising undergraduate and graduate students, post-doctoral fellows, and staff from diverse scientific, engineering, and cultural backgrounds. His lab actively recruits Canadian/permanent resident graduate students for projects on single extracellular vesicle and protein detection in cancer and infectious diseases, leveraging microfluidics and wearables for biomarker discovery. The Juncker Lab operates from the McGill University & Genome Quebec Innovation Centre (740 Dr. Penfield Avenue, Room 6206). It maintains a collaborative, multicultural environment focused on developing transformative micro- and nano-bioengineering technologies with significant potential impact on human health diagnostics and treatment.
Gabriela V. Cohen Freue is an Associate Professor in the Department of Statistics at the University of British Columbia (UBC), Vancouver Campus, and holds a Canada Research Chair (CRC Tier 2). She leads an interdisciplinary research program focusing on developing robust statistical methodologies for analyzing high-dimensional data in genomics and proteomics, with applications in medical sciences. Her work addresses challenges such as outliers, collinearity, and measurement errors, with applications in biomarker discovery for diseases like multiple sclerosis, cardiovascular disorders, and asthma. Her academic journey includes collaborations across disciplines, including with the BC Cancer Agency, PROOF Centre of Excellence, and iCAPTURE. She has pioneered methods like the Penalized Elastic Net S-Estimator (PENSE) and contributed to proteomic data analysis tools such as the Protein Group Code Algorithm (PGCA). She also co-developed the MDQC quality control method for microarrays. Research interests include robust regression, biomarker development, and statistical methods for big data. Her team includes postdocs, PhD, and MSc students, with a focus on training in both statistical rigor and interdisciplinary collaboration. Notable grants include a CANSSI Collaborative Research Team Project (CRT) award for robust causal inference and prediction modeling. Teaching responsibilities span statistical consulting, high-dimensional biological data analysis, and generalized linear models. She emphasizes active learning and real-world problem-solving in her courses. Her lab’s work is supported by grants from the Data Science Institute (DSI) and collaborations with institutions like the PROOF Centre. Alumni of her group hold positions in academia (e.g., George Mason University) and industry (e.g., Merck, BC Cancer Research Centre).
Istvan Albert is a Research Professor of Bioinformatics at Pennsylvania State University , affiliated with the Department of Biochemistry and Molecular Biology . He leads the Bioinformatics Consulting Center and teaches BMMB 852: Applied Bioinformatics . Research Interests: Specializing in bioinformatics, large-scale biological data analysis, microarray and sequence analysis, scientific programming, algorithm development, and database-driven web development. His work spans gene ontology visualization , RNA-Seq analysis , and coronavirus research . Software Development: Created GeneScape for gene function visualization and bio for bioinformatics workflows. Maintains the Biostar Handbook series and the Biostars Q&A Forum , a leading bioinformatics resource.
Charles J. Taylor is Professor of Chemistry and Chair of the Chemistry Department at Pomona College, where he has served since 2002. An analytical chemist specializing in instrumental techniques for volatile organic compound (VOC) analysis, his work bridges medical diagnostics, environmental monitoring, and chemical sensing applications. His educational background includes: Ph.D. from University of Minnesota Bachelor of Arts from Macalester College Taylor's research focuses on developing rapid diagnostic methods through VOC analysis, leveraging microhotplate arrays, Raman spectroscopy, and polymer-carbon composites. His work spans biological systems (nematode chemotaxis, wine fermentation flavor compounds) and environmental applications (trace element profiling in coffee beans). Students in his lab gain hands-on experience with advanced analytical instrumentation and multivariate data analysis. Analysis of his publications reveals consistent themes in chemical sensing materials development, with strong emphasis on microsensor arrays, NASA-collaborative electronic nose projects, and applications in medical/environmental diagnostics. His work demonstrates interdisciplinary integration of materials science, analytical chemistry, and data analysis. His scientific achievements have been recognized with: NASA Board Award for Copolymers for Sensors (2013) NASA Board Award for SO 2 Detection (2012) Provisional U.S. Patent #60/861-617 (2007) Multiple NASA Tech Brief Awards (2007) Taylor actively mentors undergraduate researchers, with students co-authoring publications on diverse projects from medical diagnostics to environmental trace analysis. His teaching includes Advanced Analytical Chemistry, Environmental Chemistry, and General Chemistry, emphasizing practical laboratory experience. Research funding has supported instrumentation development and NASA-collaborative sensor projects. His laboratory focuses on chemical sensing materials development, particularly microhotplate-based sensor arrays and VOC analysis systems, with ongoing collaborations with NASA's Jet Propulsion Laboratory for electronic nose applications and environmental monitoring solutions.
Sophie Dove is an Honorary Associate Professor at the School of Biological Sciences , University of Queensland, and an Affiliate Associate Professor at the Global Change Institute . Her research focuses on coral reef photobiology, climate change impacts, and symbiotic relationships in marine ecosystems. PhD in Biological Sciences, University of Sydney MA in Philosophy, University of Southern California MA (Hons) in Mathematics and Philosophy, University of Edinburgh Her work examines coral-dinoflagellate symbiosis , particularly how host and symbiont interactions maintain reef productivity under climate stress. Key questions include the role of symbiont parasitism, coral heterotrophy, and reef accretion-erosion balance under ocean acidification and warming. She collaborates with institutions like the Great Barrier Reef Marine Park Authority and CSIRO Publishing. Recent publications span coral bleaching mechanisms , ocean acidification effects , and biochemical adaptations in symbiotic organisms. Her studies integrate molecular biology, biogeochemistry, and ecophysiology to predict reef futures under climate stress. She has contributed to scientific consensus reports on the Great Barrier Reef and developed methodologies for analyzing coral and sponge physiology. Her interdisciplinary approach bridges marine ecology, protein biochemistry, and climate science.
Hatice Altug is a Full Professor at EPFL's Institute of Bioengineering within the School of Engineering, where she leads the Bionanophotonic Systems Laboratory. Her research integrates nanophotonics, plasmonics, and microfluidics to develop advanced biosensors for real-time molecular diagnostics. She holds dual roles in EPFL's doctoral programs and academic committees. Education: PhD in Applied Physics, Stanford University (2000-2007) B.S. in Physics, Bilkent University (1996-2000) Her research centers on creating label-free, high-sensitivity optical biosensors using nanophotonic technologies. Key innovations include dielectric metasurfaces for mid-infrared spectroscopy, AI-enhanced detection platforms, and portable nanoplasmonic imagers for point-of-care diagnostics. Her work bridges fundamental light-matter interactions with clinical applications like sepsis monitoring and cancer biomarker detection. Her publications emphasize nanophotonic biosensor design, metasurface applications, and single-cell analysis. Recent trends show increased focus on AI integration, vibrational spectroscopy, and wafer-scale manufacturing for clinical translation. Awards & Honors: Optical Society Fellow (2020) Presidential Early Career Award (PECASE, 2011) ERC Consolidator Grant (2016) IEEE Photonics Society Young Investigator Award (2011) She mentors numerous PhD students and leads interdisciplinary teams developing optofluidic platforms. Her laboratory pioneers nanoplasmonic microarrays and collaborates globally on projects like neurodegenerative disease biomarker detection. She co-directs EPFL's doctoral program in photonics and champions women in STEM through executive roles in diversity initiatives.
Fabian Pfrengle is a full Professor of Organic Chemistry at the Institute of Organic Chemistry , Department of Natural Sciences and Sustainable Resources , University of Natural Resources and Life Sciences Vienna (BOKU). He previously led research groups at the Max Planck Institute of Colloids and Interfaces (2013-2020) and worked at The Scripps Research Institute (2010-2013). Research Focus: His work bridges carbohydrate chemistry and plant biology , specializing in plant cell wall glycans and glycosyltransferases . He develops synthetic glycan arrays for enzyme characterization and investigates immune response triggering mechanisms in plants through oligosaccharide fragments . His projects include automated polysaccharide synthesis and liposome-based immune tolerance applications. Publication Trends: His 15 most recent articles emphasize chemical synthesis of sugar nucleotides , plant glycan arrays , and enzyme specificity analysis , reflecting his focus on carbohydrate engineering and plant immunity . Key subfields include UDP-sugar derivatization , Xylan structure-function relationships , and Glycosyltransferase profiling . Grants & Projects: Currently leads 5 major projects including Automated Algal Polysaccharide Synthesis (EU-funded, 2023-2028) and Synthetic Glycan Ligands for Plant Immune Receptors (FWF-funded, 2022-2026). His research also explores thrombocyte biology and Rhamnogalacturonan-II fragments with support from FWF and City of Vienna . Community Service: Serves on editorial boards ( Monatshefte für Chemie , 2021-present) and as reviewer for 12 journals including JACS Au , Nature Communications , and Angewandte Chemie . Member of professional societies: Gesellschaft Österreichischer Chemiker (2020), Deutscher Hochschulverband (2019), and Gesellschaft Deutscher Chemiker (2008).
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Huiyan Li, PhD, P.Eng., is an Associate Professor in the Department of Biomedical Engineering at the University of Guelph. Her research focuses on developing micro/nanoscale biosensors and lab-on-a-chip technologies for cancer diagnostics and personalized medicine. Dr. Li holds a Ph.D. in Biomedical Engineering from McGill University and completed postdoctoral training at Harvard Medical School/Massachusetts General Hospital. Her multidisciplinary research integrates biosensing, micro/nanofabrication, bio-optics/electronics, and computational tools to study cancer molecular complexity. Current openings exist for M.A.Sc. students interested in biosensing research. Key research areas include extracellular vesicle analysis, multiplexed immunoassays, magnetic/nanoparticle-enhanced bioassays, and graphene-based biomedical sensors. Recent work emphasizes point-of-care diagnostics and enhanced protein detection via novel material integration. Teaching responsibilities include ENGG 6301 (Advanced Micro/Nano Biotechnology) and undergraduate courses in bio-instrumentation and biomedical signal processing. Her work spans biomaterials classification, microfluidic systems, and antimicrobial nanocomposite development. Research outputs emphasize scalable microarray formats, EV-based biomarker discovery, and sensor sensitivity enhancement through nanomaterial innovations. Current projects address EV concentration measurement, 3D antibody microarrays, and magnetic-responsive hydrogel discs for bioassay improvements.
Charu Gupta Kumar is a Research Professor in the Department of Bioengineering at the University of Illinois Urbana-Champaign, affiliated with the Neuroscience program. Her research focuses on systems and computational biology, integrating computational genomics, bioinformatics, and systems biology approaches to study microbiome/pathogen dynamics, neurological diseases, and evolutionary processes. She leads the Systems and Computational Biology Group, emphasizing interdisciplinary methodologies to address complex biological questions. Her academic roles include a zero-time appointment in the Department of Neuroscience (2013–present) and service as an admission reviewer for the Carle Illinois College of Medicine (2020–2022). She advises a diverse cohort of undergraduate and graduate students engaged in bioengineering and computational biology projects. Her work bridges environmental microbiology with human health, exploring astrocyte roles in neurological disorders like glioblastoma and autism, and investigating evolutionary mechanisms of metabolic networks across species. Publications highlight contributions to bovine genomics, microbial community analysis in subsurface environments, and computational tools for genomic data management. Her research trends emphasize translational applications of computational biology to environmental and clinical challenges, with recent focus on microbiome-disease interactions and astrocyte signaling pathways. Advising spans mentoring over 18 students across bioengineering and computer science disciplines, with notable alumni advancing to institutions like MIT and Johns Hopkins. She collaborates with跨学科 teams in bioengineering and neuroscience, contributing to the broader Grainger College of Engineering research ecosystem.
